![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
A61P 35/00 | |||
C07K 16/28 | |||
C07K 16/18 | |||
A61K 51/10 |
(11) | Number of the document | 2015775 |
(13) | Kind of document | T |
(96) | European patent application number | 07724950.6 |
Date of filing the European patent application | 2007-04-26 | |
(97) | Date of publication of the European application | 2009-01-21 |
(45) | Date of publication and mention of the grant of the patent | 2011-06-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2007/004026 |
Date | 2007-04-26 |
(87) | Number | WO 2007/128557 |
Date | 2007-11-15 |
(30) | Number | Date | Country code |
06090067 | 2006-05-03 | EP | |
800011 P | 2006-05-15 | US |
(72) |
SIEGER, Stephanie, DE
BERNDORFF, Dietmar, DE
DINKELBORG, Ludger, DE
TIJINK, Bernhard, Marcel, NL
VAN DONGEN, Augustinus, Antonius, Maria, Silvester, NL
|
(73) |
Vereniging VU-Windesheim,
Kamer 3 E-15 De Boelelaan 1105, 1081 HV Amsterdam,
NL
Bayer Pharma Aktiengesellschaft, Müllerstrasse 178, 13353 Berlin, DE |
(54) | COMBINATION OF AN ANTI EDB FIBRONECTIN DOMAIN ANTIBODY L19-SIP AND AN ANTI-EGFR ANTIBODY |
COMBINATION OF AN ANTI EDB FIBRONECTIN DOMAIN ANTIBODY L19-SIP AND AN ANTI-EGFR ANTIBODY |